Richter transformation develops in 2%–10% of CLL cases, often with rapid clinical decline, limited chemotherapy efficacy, and ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 2:30 PM ESTCompany ParticipantsDave Gancarz - Chief Business ...

Non-GBM Product Revenue Expectation -- Expected contribution of $15-$25 million in 2026, compared to $10 million in 2025, ...

NovoCure Limited (NASDAQ:NVCR) Q4 2025 Earnings Call Transcript February 26, 2026 NovoCure Limited beats earnings ...

The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 1:00 PM ESTCompany ParticipantsJoshua Bleharski - ...

Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients with progressive non–small cell lung cancer (NSCLC) and progressive SCLC ...

Clonal haematopoiesis of indeterminate potential (CHIP) is an ageing-related condition associated with a substantial fraction of leukocytes descending from a single somatically mutated haematopoietic ...

A protein’s life is anything but simple. Discover how transcription, translation, folding, modification, and degradation work together to preserve proteome integrity.

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.